資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32177
|
| 標題: | Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms |
| 作者: | Lai, Chih-Cheng
Chen, Chi-Chung
Lu, Ying-Chen
Lin, Tsuey-Pin
Chuang, Yin-Ching
Tang, Hung-Jen |
| 貢獻者: | Chi Mei Med Ctr, Dept Intens Care Med
Chi Mei Med Ctr, Dept Med Res
Natl Chiayi Univ, Dept Food Sci
Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
Chi Mei Med Ctr, Dept Internal Med
Chi Mei Med Ctr, Dept Med |
| 關鍵字: | cefoperazone-sulbactam
extended-spectrum beta-lactamases
Escherichia coli
Klebsiella pneumoniae
multidrug-resistant organisms |
| 日期: | 2018 |
| 上傳時間: | 2019-11-15 15:43:53 (UTC+8) |
| 出版者: | DOVE MEDICAL PRESS LTD |
| 摘要: | Objectives: This study aims to assess the in vitro activity of different cefoperazone-sulbactam ratios against different multidrug-resistant organisms (MDROs). Materials and methods: Minimum inhibitory concentrations (MICs) and susceptibility rates of cefoperazone, sulbactam and cefoperazone-sulbactam at fixed ratios of 2:1, 1:1 and 1:2 against 344 MDRO clinical isolates, including extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (n=58), ESBL-producing Klebsiella pneumoniae (n=58), carbapenem-resistant Enterobacteriaceae (n=57), carbapenem-resistant Pseudomonas aeruginosa (n=49) and carbapenem-resistant Acinetobacter baumannii (n=122), were measured. Results: Combined treatment with sulbactam and cefoperazone resulted in decreased MIC50 values across all MDROs, as well as decreases in most MIC90 values, except for carbapenem-resistant Enterobacteriaceae and carbapenem-resistant P. aeruginosa (MIC90 values remained >64 mg/L). Susceptibility rates of treatment with cefoperazone alone against all MDROs were much lower than that of cefoperazone-sulbactam combination (all P<0.05), except in carbapenem-resistant P. aeruginosa. Additionally, the susceptibility rate gradually increased as the ratio of cefoperazone-sulbactam was adjusted from 2:1 to 1:1 and to 1:2 for carbapenem-resistant Enterobacteriaceae, ESBL-producing K. pneumoniae and carbapenem-resistant A. baumannii. There were no significant ratio-dependent changes in susceptibility rates with cefoperazone-sulbactam in carbapenem-resistant P. aeruginosa. Conclusion: Adding sulbactam enhances cefoperazone activity against most MDROs excluding carbapenem-resistant P. aeruginosa, and the activity of cefoperazone-sulbactam against these MDROs is greatest at a ratio of 1: 2, followed by ratios of 1:1 and 2:1. |
| link: | http://dx.doi.org/10.2147/IDR.S175257 |
| 關聯: | Infection and Drug Resistance, v.11, pp.1441-1445 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.2147-IDR.S175257.pdf | | 132Kb | Adobe PDF | 365 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1494 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
